In addition, in many cancer types, where E2F transcription factors are activated, due to retinoblastoma (Rb) protein mutations and/or amplification of Cyclin D or Cyclin E genes, all the relevant downstream target genes are found to be upregulated. The gene discussed is RB1; the disease is cancer.